The Role of Mutant IDH1 and IDH2 Inhibitors in the Treatment of Acute Myeloid Leukemia.
Document Type
Journal Article
Publication Date
10-31-2017
Journal
Annals of Hematology
DOI
10.1007/s00277-017-3161-0
APA Citation
Nassereddine, S., Lap, C., Haroun, F., & Tabbara, I. (2017). The Role of Mutant IDH1 and IDH2 Inhibitors in the Treatment of Acute Myeloid Leukemia.. Annals of Hematology, (). http://dx.doi.org/10.1007/s00277-017-3161-0
Peer Reviewed
1
